Lck抑制剂

Lck Inhibitor是新型的Lck抑制剂,IC50为7 nM。

信号通路 >> 蛋白酪氨酸激酶 >> SRC

研究领域 >> 炎症/免疫

[1]. Martin, Matthew W.; Newcomb, John; Nunes, Joseph J.; et al. Structure-Based Design of Novel 2-Amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as Potent and Orally Active Inhibitors of Lymphocyte Specific Kinase (Lck): Synthesis, SAR, and In Vivo Anti-Inflammatory Activity. Journal of Medicinal Chemistry (2008), 51(6), 1637-1648.

[2]. Liew, Chin Y.; Ma, Xiao H.; Liu, Xianghui; Yap, Chun W. SVM Model for Virtual Screening of Lck Inhibitors. Journal of Chemical Information and Modeling (2009), 49(4), 877-885.

萨拉卡蒂尼(AZD0530) | PP2 (AG 1879) | A 419259三盐酸盐 | N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-基]-N'-[2-氟-4-[(2-(甲基氨基甲酰基)吡啶-4-基)氧]苯基]脲 | 2,3-二氢-N,N-二甲基-2-氧代-3-[(4,5,6,7-四氢-1H-吲哚-2-基)亚甲基] -1H-吲哚-5-磺酰胺 | 4-氨基-1-叔丁基-3-(1’-萘)吡唑并[3,4-d]嘧啶 | 2,6-二甲基苯基 N-[2,4-二(甲氧基)苯基][2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基甲酸酯 | 培利替尼 | 7-二甲氧基-N-(4-苯氧基苯基)- 氨基喹唑啉 | ENMD-2076 | PD173955 | TG 100572盐酸盐 | N4-(5-环丙基-1H-吡唑-3-基)-N2-[[3-异丙基-5-异恶唑基]甲基]-6-(4-甲基-1-哌嗪基)-2,4-嘧啶二胺 | AD80 | 蛋白磷酸酯酶-1(抗原)